Navigation Links
Milestone Scientific Announces Resignation of CEO
Date:3/18/2009

Chairman to Serve as Interim CEO until Executive Search for Replacement is Completed

Planned Investor Conference Call Rescheduled to Thursday, March 26, 2009 at 4:15 PM ET

LIVINGSTON, N.J., March 18 /PRNewswire-FirstCall/ -- Milestone Scientific Inc. (OTC Bulletin Board: MLSS), the recognized leader in advanced injection technologies, today announced that Leonard Osser, Chairman of the Board, will temporarily assume the post of Interim Chief Executive Officer upon the resignation of Joe Martin, effective March 27, 2009, as CEO and Director of the Company. Martin is leaving to pursue new career opportunities.

Yesterday, Milestone filed its Form 10K with the U.S. Securities & Exchange Commission for the year ended December 31, 2008.

Key financial highlights of the 2008 results compared to 2007 reflected:

  • Year-over-year revenue growth of 5%
  • Rise in gross profit margins, which increased to 60% from 55%
  • 19% decline in operating expenses
    • 13% reduction in sales, general and administrative costs
    • 58% decrease in research and development expenses
  • 60% reduction in net losses for the year
  • 56% decrease in product inventories
  • 55% decline in accounts payable
  • 70% reduction in net cash used in operating activities

The teleconference originally scheduled to begin tomorrow morning, March 19, 2009, at 11:00 AM ET has been rescheduled to Thursday, March 26, 2009, beginning at 4:15 PM ET. At that time, investors are encouraged to join management in a discussion regarding the financial results, changes in executive management and developments relating to its business and growth strategy. The rescheduled conference call can be accessed by dialing toll-free 1-800-366-7640. For those unable to participate at that time, a replay of the teleconference can be accessed domestically by dialing 1-800-405-2236 and enter the passcode 11127369#. The replay will be available for 90 days.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(R) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The STA Single Tooth Anesthesia System(TM), a computer-controlled local anesthesia delivery system, uses this technology to provide dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at www.milesci.com and www.STAis4U.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and uncertainties and are based on assumptions involving judgments with respect to future economic, competitive and market conditions and future business decisions, all of which are difficult or impossible to predict accurately and many of which are beyond Milestone's control. Some of the important factors that could cause actual results to differ materially from those indicated by the forward-looking statements are general economic conditions, failure to achieve expected revenue growth, changes in our operating expenses, adverse patent rulings, FDA or legal developments, competitive pressures, changes in customer and market requirements and standards, and the risk factors detailed from time to time in Milestone's periodic filings with the Securities and Exchange Commission, including without limitation, Milestone's Annual Report on Form 10-KSB for the year ended December 31, 2007. The forward looking-statements in this press release are based upon management's reasonable belief as of the date hereof. Milestone undertakes no obligation to revise or update publicly any forward-looking statements for any reason.

    FOR MORE INFORMATION, PLEASE CONTACT:
    Elite Financial Communications Group
    Dodi Handy, President and CEO
    For Media Inquiries: Tiffany Korkis or Kathy Addison, Directors,
    Elite Media Group
    407-585-1080 or via email at mlss@efcg.net


'/>"/>
SOURCE Milestone Scientific Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Materials for Medical Devices Database Reaches Milestone
2. Reveille Software Reaches Customer Milestone and Expands Executive Team
3. Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone
4. Milestone Scientific to Exhibit at the Chicago Dental Societys 144th Midwinter Meeting
5. SOLX Announces 1000th Gold Shunt Implantation Milestone for Glaucoma Treatment
6. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
7. Mission Pharmacal Celebrates Historic Milestone
8. Turner Reaches Milestone on $323 Million Virtua West Jersey Replacement Hospital in Voorhees, N.J.
9. Concentric Medical Reaches Important Stroke Milestone
10. Hand Transplantation Marks Historical 10-Year Milestone
11. Prism Pharmaceuticals to Receive $10 Million Milestone Payment from Paul Capital Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Those who have ... these feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as ... Michigan, has released tools for healthy coping following a traumatic event. , Trauma sufferers ...
(Date:6/24/2016)... ... June 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced ... attorneys chosen by their peers for this recognition are considered among the top 2 ... received special honors as members of this year’s Legal Elite Hall of Fame: ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Strategic Capital Partners, LLC (SCP) in ... investment capital for emerging technology companies. SCP has delivered investment events and ... more than a million dollars of capital investment for five companies. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... June 24, 2016   Bay Area Lyme ... Dean Center for Tick Borne Illness , ... Rehabilitation, MIT Hacking Medicine, University of California, Berkeley, ... announced the five finalists of Lyme Innovation ... More than 100 scientists, clinicians, researchers, entrepreneurs, and ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, 2016 ... mobile pulmonary function testing company, is now able to perform sophisticated ... by ndd Medical Technologies , Inc. Patients ... hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL patients ... get any needed testing done in the comfort of her own ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: